- $6.18bn
- $8.14bn
- $3.10bn
- 87
- 39
- 86
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,772 | 2,705 | 2,991 | 3,184 | 3,095 |
Cost of Revenue | |||||
Gross Profit | 1,193 | 1,188 | 1,336 | 1,432 | 1,431 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,208 | 2,236 | 2,405 | 2,607 | 2,517 |
Operating Profit | 564 | 468 | 586 | 578 | 578 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 566 | 460 | 534 | 527 | 484 |
Provision for Income Taxes | |||||
Net Income After Taxes | 437 | 342 | 413 | 401 | 377 |
Net Income Before Extraordinary Items | |||||
Net Income | 437 | 342 | 413 | 401 | 377 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 437 | 342 | 413 | 401 | 377 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.62 | 2.41 | 2.47 | 2.56 | 2.27 |
Dividends per Share |